114 related articles for article (PubMed ID: 1696545)
1. p-chlorophenylalanine attenuates the pituitary-adrenocortical response to 5-HT1A receptor agonists in mice.
Matsuda T; Kanda T; Seong YH; Baba A; Iwata H
Eur J Pharmacol; 1990 Jun; 181(3):295-7. PubMed ID: 1696545
[TBL] [Abstract][Full Text] [Related]
2. Mechanisms of serotonin receptor agonist-induced activation of the hypothalamic-pituitary-adrenal axis in the rat.
Calogero AE; Bagdy G; Szemeredi K; Tartaglia ME; Gold PW; Chrousos GP
Endocrinology; 1990 Apr; 126(4):1888-94. PubMed ID: 2156670
[TBL] [Abstract][Full Text] [Related]
3. Serotonin agonists cause parallel activation of the sympathoadrenomedullary system and the hypothalamo-pituitary-adrenocortical axis in conscious rats.
Bagdy G; Calogero AE; Murphy DL; Szemeredi K
Endocrinology; 1989 Nov; 125(5):2664-9. PubMed ID: 2551661
[TBL] [Abstract][Full Text] [Related]
4. Hypothermia induced by the putative 5-HT1A agonists LY165163 and 8-OH-DPAT is not prevented by 5-HT depletion.
Hutson PH; Donohoe TP; Curzon G
Eur J Pharmacol; 1987 Nov; 143(2):221-8. PubMed ID: 2961583
[TBL] [Abstract][Full Text] [Related]
5. Gonadectomy changes the pituitary-adrenocortical response in mice to 5-HT1A receptor agonists.
Matsuda T; Nakano Y; Kanda T; Iwata H; Baba A
Eur J Pharmacol; 1991 Aug; 200(2-3):299-304. PubMed ID: 1838334
[TBL] [Abstract][Full Text] [Related]
6. Para-chlorophenylalanine prevents feeding induced by the serotonin agonist 8-hydroxy-2-(di-n-propylamino) tetralin (8-OH-DPAT).
Dourish CT; Hutson PH; Curzon G
Psychopharmacology (Berl); 1986; 89(4):467-71. PubMed ID: 2428076
[TBL] [Abstract][Full Text] [Related]
7. Anticonflict effect of the putative serotonin receptor agonist 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT).
Engel JA; Hjorth S; Svensson K; Carlsson A; Liljequist S
Eur J Pharmacol; 1984 Oct; 105(3-4):365-8. PubMed ID: 6239785
[TBL] [Abstract][Full Text] [Related]
8. Serotonin 5-HT1A receptor-mediated hypothermia in mice: absence of spare receptors and rapid induction of tolerance.
Meller E; Chalfin M; Bohmaker K
Pharmacol Biochem Behav; 1992 Oct; 43(2):405-11. PubMed ID: 1359573
[TBL] [Abstract][Full Text] [Related]
9. Relationship of increased food intake and plasma ACTH levels to 5-HT1A receptor activation in rats.
Gilbert F; Dourish CT; Brazell C; McClue S; Stahl SM
Psychoneuroendocrinology; 1988; 13(6):471-8. PubMed ID: 2907164
[TBL] [Abstract][Full Text] [Related]
10. Agonist activity of a novel compound, 1-[3-(3,4-methylenedioxyphenoxy)propyl]-4-phenyl piperazine (BP-554), at central 5-HT1A receptors.
Matsuda T; Seong YH; Aono H; Kanda T; Baba A; Saito K; Tobe A; Iwata H
Eur J Pharmacol; 1989 Oct; 170(1-2):75-82. PubMed ID: 2533078
[TBL] [Abstract][Full Text] [Related]
11. Central 5-HT1A receptors inhibit adrenocortical secretion.
Welch JE; Farrar GE; Dunn AJ; Saphier D
Neuroendocrinology; 1993; 57(2):272-81. PubMed ID: 8510803
[TBL] [Abstract][Full Text] [Related]
12. Direct evidence for an important species difference in the mechanism of 8-OH-DPAT-induced hypothermia.
Bill DJ; Knight M; Forster EA; Fletcher A
Br J Pharmacol; 1991 Aug; 103(4):1857-64. PubMed ID: 1833017
[TBL] [Abstract][Full Text] [Related]
13. The behavioural effects of 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT) in mice.
Yamada J; Sugimoto Y; Horisaka K
Eur J Pharmacol; 1988 Sep; 154(3):299-304. PubMed ID: 2976671
[TBL] [Abstract][Full Text] [Related]
14. WAY-100635 inhibits 8-OH-DPAT-stimulated oxytocin, ACTH and corticosterone, but not prolactin secretion.
Vicentic A; Li Q; Battaglia G; Van de Kar LD
Eur J Pharmacol; 1998 Apr; 346(2-3):261-6. PubMed ID: 9652368
[TBL] [Abstract][Full Text] [Related]
15. Reduction of 5-hydroxytryptamine (5-HT)(1A)-mediated temperature and neuroendocrine responses and 5-HT(1A) binding sites in 5-HT transporter knockout mice.
Li Q; Wichems C; Heils A; Van De Kar LD; Lesch KP; Murphy DL
J Pharmacol Exp Ther; 1999 Dec; 291(3):999-1007. PubMed ID: 10565817
[TBL] [Abstract][Full Text] [Related]
16. Activation of the 5-HT1A receptor subtype increases rat plasma ACTH concentration.
Gilbert F; Brazell C; Tricklebank MD; Stahl SM
Eur J Pharmacol; 1988 Mar; 147(3):431-9. PubMed ID: 2897920
[TBL] [Abstract][Full Text] [Related]
17. Single-dose 8-OH-DPAT pretreatment does not induce tachyphylaxis to the 5-HT release-reducing effect of 5-HT1A autoreceptor agonists.
Hjorth S
Eur J Pharmacol; 1991 Jun; 199(2):237-42. PubMed ID: 1835441
[TBL] [Abstract][Full Text] [Related]
18. 5-HT depletion with 5,7-DHT, PCA and PCPA in mice: differential effects on the sensitivity to 5-MeODMT, 8-OH-DPAT and 5-HTP as measured by two nociceptive tests.
Eide PK; Hole K; Berge OG; Broch OJ
Brain Res; 1988 Feb; 440(1):42-52. PubMed ID: 2965956
[TBL] [Abstract][Full Text] [Related]
19. Behavioural evidence for functional interactions between 5-HT-receptor subtypes in rats and mice.
Berendsen HH; Broekkamp CL
Br J Pharmacol; 1990 Nov; 101(3):667-73. PubMed ID: 2150180
[TBL] [Abstract][Full Text] [Related]
20. The pharmacology of the hypothermic response in mice to 8-hydroxy-2-(di-n-propylamino)tetralin (8-OH-DPAT). A model of presynaptic 5-HT1 function.
Goodwin GM; De Souza RJ; Green AR
Neuropharmacology; 1985 Dec; 24(12):1187-94. PubMed ID: 2869435
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
